CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Anita Pelecanos

OPENALEX: A5002442195↗ORCID: 0000-0003-0197-4504↗

Affiliations

Organizations

QIMR Berghofer Medical Research Instituteauthorship · AU The University of Queenslandauthorship · AU

Public evidence

2 connected articles

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.2025 · Europe PMC Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Anita Pelecanos - Medical Cannabis Research Engine